Effects of Isolated Rooms on the Prevalence of Hospital Acquired Pneumonia in a Respiratory ICU

This study has been completed.
Sponsor:
Information provided by:
Eskisehir Osmangazi University
ClinicalTrials.gov Identifier:
NCT01250691
First received: November 30, 2010
Last updated: NA
Last verified: January 2004
History: No changes posted
  Purpose

This study will carry out in the ICU. Objectives of the study are to determine the frequency of HAP and the effect of isolated rooms on the frequency of pneumonia in the ICU.


Condition Intervention
Pneumonia
Intensive Care Unit
Other: ward-type ICU

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Epidemiologic Study of Hospital Acquired Pneumonia in a Respiratory ICU

Resource links provided by NLM:


Further study details as provided by Eskisehir Osmangazi University:

Enrollment: 532
Study Start Date: January 2004
Study Completion Date: August 2010
Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
hospital acquired pneumonia
isolated rooms Other: ward-type ICU
frequency of hospital acquired pneumonia in the ICU
Other Name: frequency of hospital acquired pneumonia in the ICU
ward-type ICU

Detailed Description:

In the present study, it was aimed to determine the incidence, causative agents, antimicrobial resistance, and risk factors for lower respiratory tract infections in patients followed in the ICU for the last 4 years. The effect of reconfiguration from a ward-type ICU consisting one large room to an ICU with isolated rooms with two beds on the incidence of HAP was also determined.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All of the patients who had been admitted to the ICU during this period were included in the study

Criteria

Inclusion Criteria:

  • adult patients,
  • admitted to the ICU

Exclusion Criteria:

  • trauma, surgery or burned patients
  • patients under 18
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01250691

Locations
Turkey
Eskisehir Osmangazi University
Eskisehir, Merkez, Turkey, 26040
Osmangazi University
Eskisehir, Merkez, Turkey, 26040
Eskisehir Osmangazi University
Eskisehir, Turkey, 26040
Sponsors and Collaborators
Eskisehir Osmangazi University
Investigators
Study Chair: Irfan Ucgun, As.Prof.Dr. Eskisehir Osmangazi University, Medical Faculty
  More Information

No publications provided

Responsible Party: Eskisehir Osmangazi University, Department of Chest Diseases, Intensive Care Unit, Eskisehir Osmangazi University
ClinicalTrials.gov Identifier: NCT01250691     History of Changes
Other Study ID Numbers: HAP-OU-isolation
Study First Received: November 30, 2010
Last Updated: November 30, 2010
Health Authority: Turkey: Ethics Committee

Keywords provided by Eskisehir Osmangazi University:
pneumonia
ICU
isolation room
clinical epidemiology
infection control

Additional relevant MeSH terms:
Pneumonia
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections

ClinicalTrials.gov processed this record on July 28, 2014